Safety of the Herpes Zoster Subunit Vaccine in Lupus
Conditions
Systemic Lupus Erythematosus
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
NYU Langone Health, New York, New York, United States
Contact: Principal Investigator (Amit Saxena, MD)Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States
Study leads
Amit Saxena, MD
Principal Investigator
NYU Langone Health